Misplaced Pages

Orthomolecular medicine: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 15:00, 26 January 2007 editTheNautilus (talk | contribs)1,377 edits →History and development: remove redundant link, already multiples in controversy← Previous edit Revision as of 08:32, 29 January 2007 edit undoValjean (talk | contribs)Autopatrolled, Extended confirmed users, IP block exemptions, Pending changes reviewers, Rollbackers95,275 edits Never remove sources unless you can justify it.Next edit →
Line 14: Line 14:
Since ] the orthomolecular field has diversified, but the term is still often closely associated with Pauling's advocacy of multi-gram doses of ] for optimal health. Partly for this reason, detractors of orthomolecular ideas have described them entirely in terms of megadose nutrient therapy. Cassileth, a widely quoted critic of Pauling's ideas, states: "In 1968, the Nobel-prize-winning scientist Linus Pauling coined the term "orthomolecular" to describe the treatment of disease with large quantities of nutrients."<ref name="cassileth"/> In this way, criticism of orthomolecular medicine has, to a large extent, been confused with much older medical traditions of high-dose vitamin therapies, such as earlier "megadose" usages of ] and ] or synthetic pharmaceutical analogues, such as ]. However, such definitions of orthomolecular therapy are not synonymous with Pauling's ideas. Since ] the orthomolecular field has diversified, but the term is still often closely associated with Pauling's advocacy of multi-gram doses of ] for optimal health. Partly for this reason, detractors of orthomolecular ideas have described them entirely in terms of megadose nutrient therapy. Cassileth, a widely quoted critic of Pauling's ideas, states: "In 1968, the Nobel-prize-winning scientist Linus Pauling coined the term "orthomolecular" to describe the treatment of disease with large quantities of nutrients."<ref name="cassileth"/> In this way, criticism of orthomolecular medicine has, to a large extent, been confused with much older medical traditions of high-dose vitamin therapies, such as earlier "megadose" usages of ] and ] or synthetic pharmaceutical analogues, such as ]. However, such definitions of orthomolecular therapy are not synonymous with Pauling's ideas.


Based on investigational scientific studies, single blinded and double blinded randomized controlled trials, clinical experience, and case histories, claims have been made that therapeutic nutrition can treat, or sometimes cure, ], ], ], ], ], ], ], ], acute ], ], ], ], ], ] & ] (including ]), ],<ref>Plaza SW, Lamson DW. . Alt Medicine Review, Vol 10, No 1.</ref> ], "],<ref>Hoffer A, et al. . Orthomolecular Medicine News Service, 1 Jul 2005</ref> ], ], ], ], ], ], ], ], ], ], ] and ], ] problems, ],<ref>Princeton Brain Bio Center. Brochure, distributed to patients. Skillman, N.J., 1983, The Center.</ref> ], ], ], * ], ],<ref>Skinner P, "Orthomolecular Medicine", ''Gale Encyclopedia of Alternative Medicine: Holistic medicine'', Thomson Gale, 2004.</ref> ], ], ], ] and ]. Based on investigational scientific studies, single blinded and double blinded randomized controlled trials, clinical experience, and case histories, claims have been made that therapeutic nutrition can treat, or sometimes cure, ], ], ], ], ], ], ], ], acute ], ], ], ], ], ] & ] (including ]), ],<ref>Plaza SW, Lamson DW. . Alt Medicine Review, Vol 10, No 1.</ref> ], "],<ref>Hoffer A, et al. . Orthomolecular Medicine News Service, 1 Jul 2005</ref> ], ], ], ], ], ], ], ], ], ], ] and ], ] problems, and ],"<ref>Princeton Brain Bio Center. Brochure, distributed to patients. Skillman, N.J., 1983, The Center.</ref><ref name="qw"/> ], ], ], * ], ],<ref>Skinner P, "Orthomolecular Medicine", ''Gale Encyclopedia of Alternative Medicine: Holistic medicine'', Thomson Gale, 2004.</ref> ], ], ], ] and ].


==Method== ==Method==

Revision as of 08:32, 29 January 2007

Optimum nutrition and orthomolecular medicine are nutritional health and medical approaches which posit that many diseases and abnormalities result from various chemical imbalances or deficiencies and can be prevented, treated, or sometimes cured by achieving optimal levels of naturally occurring chemical substances, such as vitamins, dietary minerals, enzymes, antioxidants, amino acids, lipotropes, essential fatty acids, prohormones, dietary fiber and intestinal short chain fatty acids. Many of the substances used are essential nutrients.

Orthomolecular medicine is explicitly practiced by relatively few conventional medical practitioners. Orthomolecular treatments are also utilized in complementary and alternative medicine fields, increasingly being integrated into OTC retail products, naturopathic medical textbooks and mainstream pharmaceuticals. The controversial field of orthomolecular psychiatry deals with the use of orthomolecular medicine to treat psychiatric problems.

The orthomolecular field is based on research in biochemistry, nutrition, medicine, and pharmaceuticals combined with the clinical experience of a number of physicians and physician scientists. It remains controversial among mainstream medical organizations and physicians, who consider many aspects to be complementary, alternative or integrative medicine . Orthomolecular proponents argue that many mainstream nutritional studies, both recent and historical, provide investigational and clinical support for their treatments and recommendations. They also argue that orthomolecular therapies are intrinsically less likely to cause dangerous side-effects or harm, since they utilize only molecules which are normally present in the body through healthy diet or normal metabolism.

History and development

Orthomolecular type treatments typically have been experimentally or empirically introduced by physicians with advanced scientific or research backgrounds when conventional medical treatments offered neither solution nor hope. Before the term "orthomolecular" was even coined, Otto Heinrich Warburg a two time Nobel laureate advocated the use of vitamins and minerals to treat illness, but found that his ideas were ignored. Orthomolecular megavitamin therapies, such as with tocopherols and ascorbates, date back to the 1930s.

The term "orthomolecular" was first used by Linus Pauling in 1968 to express the "idea of the right molecules in the right amounts within the context of psychiatry". Pauling subsequently defined "orthomolecular medicine" as "the treatment of disease by the provision of the optimum molecular environment, especially the optimum concentrations of substances normally present in the human body" or as "the preservation of good health and the treatment of disease by varying the concentrations in the human body of substances that are normally present in the body and are required for health."

Since 1968 the orthomolecular field has diversified, but the term is still often closely associated with Pauling's advocacy of multi-gram doses of vitamin C for optimal health. Partly for this reason, detractors of orthomolecular ideas have described them entirely in terms of megadose nutrient therapy. Cassileth, a widely quoted critic of Pauling's ideas, states: "In 1968, the Nobel-prize-winning scientist Linus Pauling coined the term "orthomolecular" to describe the treatment of disease with large quantities of nutrients." In this way, criticism of orthomolecular medicine has, to a large extent, been confused with much older medical traditions of high-dose vitamin therapies, such as earlier "megadose" usages of retinol and ergocalciferol or synthetic pharmaceutical analogues, such as menadione. However, such definitions of orthomolecular therapy are not synonymous with Pauling's ideas.

Based on investigational scientific studies, single blinded and double blinded randomized controlled trials, clinical experience, and case histories, claims have been made that therapeutic nutrition can treat, or sometimes cure, acne, bee sting, burns, cancer, common cold, drug addiction, drug overdose, heart diseases, acute hepatitis, herpes, influenza, mononucleosis, mushroom poisoning, neuropathy & polyneuritis (including Multiple sclerosis), osteoporosis, polio, "alcoholism, allergies, arthritis, autism, epilepsy, hypertension, hypoglycemia, migraine, clinical depression, learning disabilities, retardation, mental and metabolic disorders, skin problems, and hyperactivity," Raynaud's disease, heavy metal toxicity, radiation sickness, * Pyroluria, schizophrenia, shock, snakebite, spider bite, tetanus toxin and viral pneumonia.

Method

Orthomolecular medicine argues that some diseases reflect biochemical anomalies and that it is advantageous to recognize and to correct these anomalies at an early stage, before they result in recognizable diseases. Orthomolecular medicine posits that many typical diets are insufficient for long term health; thus, orthomolecular medical diagnoses and treatment often focus on use of natural substances found in a normal diet such as vitamins, dietary minerals, enzymes, antioxidants, amino acids, ω-3 fatty acids, ω-6 fatty acids, lipotropes, prohormones, dietary fiber and short and long chain fatty acids.

Orthomolecular therapy consists in attempting to provide optimal amounts of substances normal to the body, most commonly by oral administration. Most often, "optimal" has been a matter of the clinical judgment of the orthomolecular practitioner, who gave nutrients in accord with the clinical symptoms of the patient and his or her judgement of what is appropriate. The modern orthomolecular practitioner also uses a wide range of laboratory analyses, including those for amino acids, organic acids, vitamins and minerals, functional vitamin status, hormones, immunology, microbiology, and gastrointestinal function. However, many of these tests have not been accepted by mainstream medicine for common diagnostic use.

In the early days of orthomolecular medicine, supplementation usually meant high-dose, single-agent nutrient therapy. Most often today, the orthomolecular practitioner uses many substances: amino acids, enzymes, non-essential nutrients, hormones, vitamins, minerals, or derivate substances in a therapeutic effort to restore optimum levels for healthy young persons.

Frequently supplementation with relatively large doses of vitamins is given, and the name megavitamin therapy is popularly associated with the area. Megavitamin therapy is the administration of large amounts of vitamins, often many times greater than the recommended dietary allowance (RDA). The nominal ratio of dose to RDA to qualify for the term "megavitamin therapy" has been a matter of minor semantic debate.

Administration of short-chain fatty acids in orthomolecular practice is usually accomplished by fiber supplementation. The fatty acids are produced by fermentation of dietary fiber in the colon, then absorbed and utilized. This process is often aided by a combination of probiotics, prebiotics and "glyconutrients" added to the diet. Administration of long chain fatty acids, such as the omega-3 fatty acids alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) may be accomplished by dietary means, or by supplementation with the appropriate fats or fatty acid esters in capsule form.

Nutritional substances may also be administered by changing the diet to emphasize certain foods high in nutrients, by dietary supplementation with oral preparations such as tablets or capsules, or by intravenous injection of nutrient solutions.

Popularity

A survey released in May 2004 by the National Center for Complementary and Alternative Medicine focused on who used complementary and alternative medicine (CAM), what was used, and why it was used in the United States by adults age 18 years and over during 2002. The survey reported uses in the previous 12 months that include orthomolecular related uses: Nonvitamin, nonmineral, natural products 18.9%, Diet-based therapies 3.5%, Megavitamin therapy 2.8%. The survey did not include other popular related categories such as juicing, supplemental antioxidants, essential fatty acids, amino acids, enzymes and others.

Another recent CAM survey reported 12% of liver disease patients using the antioxidant silymarin, more than 6% used megavitamins among others, and "In all, 74% of patients reported using CAM in addition to the medications prescribed by their physician, but 26% did not inform their physician of their CAM use."

Relation to mainstream medicine

Orthomolecular medicine claims an evolving nutritional pharmacology that overlaps between natural medicine and mainstream medicine. The International Society for Orthomolecular Medicine has conventionally-trained doctors among its members and authors. However, the leading orthomolecular medicine website, Orthomolecular Medicine Online, run by the Journal of Orthomolecular Medicine, discusses differences between orthomolecular medicine and current mainstream medicine, which the website refers to as allopathic medicine.

Amongst the differences, mainstream medicine attaches great importance to rigorous double-blind randomized controlled trials to prove a treatment is effective and to exclude the placebo effect. Orthomolecular medicine proponents, on the other hand, believe that such studies overemphasize presupposed minimization of uncertainty in measurement and have instead led to false-negative results from otherwise poorly designed and executed studies that resulted in misrepresented "authoritative" disparagement of nutritional treatments. Mainstream medicine avoids use of new, unproven xenobiotic molecules whose effects are unknown, instead favoring extensively tested, clinically proven drugs, of which 20% may subsequently have unrecognized, serious adverse reactions requiring the later addition of the "black box warning", or withdrawal from market. Orthomolecular medicine holds that natural equivalent molecules, as non-toxic nutritional therapies, are often useful in the interim, before extremely expensive, time-consuming authoritative tests are available.

Individual mainstream medical proponents are sometimes dismissive of orthomolecular medicine: "Scientific research has found no benefit from orthomolecular therapy for any disease" despite strong counterexamples such as megadose niacin for dyslipidemias (1955).

Supporters claim that some aspects of orthomolecular medicine, and in particular the optimal nutrition subset, have support in mainstream scientific research in a variety of areas:

  • Studies finding that greater than RDA of selenium reduce the overall incidence of cancers
  • Studies finding that greater than RDA of "A, B6, C and E plus zinc", folic acid and selenium reduce the incidence of specific cancers
  • Studies finding that supplementation of long-chain omega-3 essential fatty acids reduced the incidence of cardiac mortality in secondary prevention trials
  • Early studies finding that vitamin E alone and vitamin C & E together reduce coronary disease mortality
  • Bruce Ames's studies on the effects of vitamins on genetic diseases and biochemical aging processes
  • The advocacy of daily multivitamins in cancer prevention by Bruce Ames and by others in a JAMA review article for "chronic disease prevention in adults"

Some of these findings have reported as not consistent with other studies. For example, see Vitamin E controversy below, a subsequent meta-analysis found a lack of benefit to single isomeric alpha tocopheryl ester forms of vitamin E supplementation. Indeed, alpha tocopheryl ester supplementation might increase the risk for congestive heart failure. The Shutes decades earlier did specifically caution about tocopherol dosage and slow buildup rates for CHF patients and those with pre-existing rheumatic heart problems; modern orthomolecular medicine has different specific nutrient recommendations for CHF patients. Reconciling and confirming the conclusions of individual nutritional studies is a subject of ongoing research.

These studies all come from mainstream medical sources that do not claim to support orthomolecular doctrine, and in at least some cases, explicitly reject claims of orthomolecular proponents that nutritional supplements are desirable. Ames supports daily USRDA multivitamin supplements as a public-policy solution to the lack of vegetables in United States diets, but has not endorsed global use of megavitamin therapy propounded by orthomolecular medicine.

The skepticism about orthomolecular medicine comes in part because some of its proponents make claims more broad than those supported by double-blind randomized controlled studies, additionally considering observational studies, clinical and anecdotal experience, single blinded controlled tests, and case histories. Proponents of orthomolecular medicine argue that, despite the extensive and expensive testing of pharmaceuticals, a number of medications have recently been withdrawn after approval due to serious adverse events, and the FDA regulatory methodology and relationship with the pharmaceutical industry has been criticized.

Nutritional supplements, such as those used in orthomolecular medicine, are less regulated than pharmaceuticals in the United States. Pharmaceuticals must be proven safe and effective to the satisfaction of the FDA before they can be marketed, whereas supplements must be proven unsafe before regulatory action can be taken. A number of orthomolecular US supplements are available in pharmaceutical versions that are sometimes quite similar in strength and general content, or in other countries are pharmaceuticals. The US regulations also have provisions to recognize a general level of safety for established nutrients that can forgo new drug safety tests. Proponents of nutritional supplement use have argued that the lower level of regulation results in cost savings for American consumers, pointing to higher supplement prices in Europe, where supplements are more tightly regulated or even unavailable.

Criticism and controversy

The conventional view amongst mainstream medical physicians is that most orthomolecular therapies are insufficiently proven for clinical use, that the scientific foundations are weak, and that the studies that have been performed are too few and too open to disputed interpretation. Orthomolecular proponents, such as Robert Cathcart who predicts that 120+ grams per day intravenous vitamin C should cure SARS and has used up to 250 grams IV vitamin C per day, have been criticised without any conventional medical trials of such intravenous vitamin C treatments.

Proponents of orthomolecular medicine argue that many mainstream physicians are unfamiliar with the concepts and clinical background of orthomolecular medicine. They dispute the interpretation of results of many mainstream studies, arguing that those interpretations or studies are "strawmen", using much lower doses, frequencies, duration or assimilable forms than they recommend or suffered from other special conditions, contamination, populations or statistical treatment often not clearly published in the documentation.

The orthomolecular field remains controversial among mainstream medical organizations, including the American Cancer Society, the American Psychiatric Association, the National Institute of Mental Health, the American Academy of Pediatrics, CHAMPUS, and the Canadian Paediatric Society. A number of individuals and organizations contest the claims, benefits, degree of evidence and toxicity. Based on testing with dosages well below orthomolecular recommendations, Linus Pauling has been criticized for making overbroad claims for the efficacy of vitamin C but Paulings' claims have received some support from tests closer to the orthomolecular recommendations during the last few years.

The relationship of mainstream medicine to orthomolecular proponents has often been adversarial; orthomolecular proponents argue that mainstream medical claimants confuse orthomolecular medicine with other, less science based modalities. The American Academy of Pediatrics labelled orthomolecular medicine a "cult" in 1976, in response to claims that orthomolecular medicine could cure childhood psychoses and learning disorders. Conventional health professionals see orthomolecular medicine as encouraging individuals to dose themselves with large amounts of vitamins and other nutritients without conventional supervision, which they worry might be damaging to health. Rare risks of non-orthomolecular "mega" dosages of vitamin relatives, which frequently involved pharmaceutical analogues such as synthetic menadione, unsupervised misuse, deliberate abuse and earlier medical treatments, may include increased risk of coronary heart disease, hypertension, thrombophlebitis, peripheral neuropathy, ataxia, neurological effects, liver toxicity, congenital abnormalities, spontaneous abortion, gouty arthritis, jaundice, kidney stones, and diarrhea. Megavitamin proponents point to an almost zero level of deaths caused by vitamins, even with large overdoses, compared to the significant numbers from pharmaceuticals, including a number of over-the-counter items.

Vitamin E controversy

The accumulated evidence of randomized clinical trials with conventional, chemically-modified alpha tocopheryl esters, containing only one kind of natural vitamin E (of eight vitamers) in the stabilized (chemically inactivated) ester form (usually acetate) have been controverted. Initial hopes for alpha tocopheryl esters (usually acetate) were based on suppositional grounds and epidemiological data that often involved the natural, full spectrum dietary forms of vitamin E (mixed R, R,R tocopherols - alpha- beta- gamma-, delta- isomers). Meta analysis of several randomized clinical trials of manufactured antioxidants, including alpha tocopheryl esters (acetate, succinate) not in an antioxidant form, have not shown any benefit to alpha tocopheryl ester supplementation for preventing coronary heart disease. Orthomolecular recommendations for the full vitamin E complex typically include an additional 25% to 200% w/w of beta-, gamma-, and delta-tocopherols. Recent scientific and medical research shows gamma-tocopherol, the most common vitamer of natural vitamin E, has unique beneficial functions and "gamma tocopherol is considered an integral component of the nutrient-based recommendations in many EU member countries."

A controversial meta-analysis published in 2005 claimed that "high dose" alpha tocopheryl esters (>=400 units/day) were associated with an all-cause mortality risk difference of 39 per 10,000 persons). Furthermore, a significant relationship was claimed between dose and all-cause mortality, with increased risk with doses exceeding 150 I.U. per day. This meta-analysis, however, was criticized on a number of grounds. One of several criticisms which the authors did not rebut was that the mortality effect was a confounder resulting entirely from excess mortality in a few studies of combined alpha-tocopheryl ester and synthetic beta carotene in heavy smokers. Known for decades, that "he antagonisms that exist between...carotene and vitamin E are complicated", this supplement and smoking exposure combination once had some academic support but synthetic "beta carotene...has previously been shown to be harmful" in smokers, a subpopulation with high oxidative stress. Long commercialized, multiple antioxidant megavitamin combinations, such as "ACES", that also include antioxidants vitamin C and selenium to recycle the first two antioxidants and aid liver peroxide detoxification, were not tested or measured.

The orthomolecularly-preferred "vitamin E", mixed (natural) R, R,R tocopherols, available for two-thirds of a century, remain to be authoritatively evaluated in tests controlled for bile, pancreatic function, certain specific heart problems and risk factors, blood levels and cofactors (vitamins C, D3, K1, K2, selenium, co-enzyme Q10, etc.) in the common orthomolecular range, 600 - 3200 IU alpha tocopherol plus 25%-200% by weight of other R, R,R tocopherols. With the exception of controlling for standard comorbidities such as heart disease, controlling for pancreatic function, various vitamin cofactors, etc. has not been felt by conventional medicine to be clinically relevant nor routinely done in clinical trials. However, naturopathic medicine texts and naturopathic physicians routinely recommend such laboratory tests of biliary and pancreatic functions in their orthomolecular-related modalities.

Time and therapeutic priority

Conventional physicians express concern that megavitamin and orthomolecular therapies used solely as alternative treatments by other practitioners, if not successful, may create dangerous delays in obtaining conventional treatments, such as radiation and chemotherapy for cancer. For example, in a highly publicized Canadian case, the chemotherapy and orthomolecular treatments of a 13-year-old cancer patient, Tyrell Dueck, were delayed, possibly fatally, due to his parents' religious beliefs, interest in alternative treatments, and lengthy legal battles. Orthomolecular medical practitioners and orthomolecular oriented naturopaths have long expressed similar concerns about conventional medicine, particularly with gut related and chronic diseases as well as viral diseases.: The use of conventional medical treatments, if not successful, may create dangerous delays in people obtaining orthomolecular treatments. It is usually possible, however, to combine orthomolecular and conventional treatments.

Other benefits

Several orthomolecular related AIDS approaches such as multivitamins, selenium and amino acids are used with reported improvements in patients. High dose vitamin C treatments have long been used clinically by some orthomolecular practitioners to treat AIDS patients; a minor 1994 in vitro laboratory study raised questions that sustained megadoses of vitamin C might inhibit some immune cells. In these situations, mainstream medical criticism arises when orthomolecular approaches are advocated as substitutes for, rather than complements to, current medical treatments.

Economic interests and politics

Some orthomolecular proponents claim partisan politics, pharmaceutical industry influence, and competitive considerations to be significant factors. Some prominent orthomolecular proponents sell lines of orthomolecular products and acceptance for some tests questioned about their benefit vary by medical affiliation such as hair analysis. The Linus Pauling Institute's funding comes mostly from National Institutes of Health. Several orthomolecular therapies have been officially sanctioned within Europe and Japan .

Notable orthomolecular doctors

Robert Cathcart
Ronald E Hunnunghake
Thomas E. Levy Glen Dettman
Archie Kalokerinos
Carl Pfeiffer Abram Hoffer
Fred Klenner
Matthias Rath David Horrobin
Richard Kunin
Hugh D. Riordan Julian Whitaker
Allan Cott

Notable orthomolecular scientists

Robert F. Cathcart
Abram Hoffer
Otto Heinrich Warburg David R. Hawkins
Linus Pauling
William J. Walsh Steve Hickey
Irwin Stone
Albert Szent-Gyorgyi

Notable Orthomolecular Journals

The Journal of Orthomolecular Medicine, founded in 1967 as the Journal of Schizophrenia, is the main publication of those involved in Orthomolecular Medicine. Abram Hoffer has written that "We had to create our own journals because it was impossible to obtain entry into the official journals of psychiatry and medicine. Before 1967 I had not found it difficult to publish reports in these journals, and by then I had about 150 articles and several books in the establishment press."

Bibliography

Advocates

  • Abram Hoffer (1998) Putting It All Together: The New Orthomolecular Nutrition, McGraw-Hill, ISBN 0-87983-633-4
  • Abram Hoffer, M.D. with Linus Pauling (2004) Healing Cancer: Complementary Vitamin & Drug Treatments, CCNM Press, ISBN 1-897025-11-4
  • David Moss (2000) Ph.D, Antioxidants Against Cancer, Equinox Press , ISBN 1881025284
  • Pauling, Linus (1986) How to Live Longer and Feel Better, W. H. Freeman and Company, ISBN 0-380-70289-4
  • Roger J. Williams, Dwight K. Kalita (1979) Physician's Handbook on Orthomolecular Medicine, Keats Publishing, ISBN 0-87983-199-5
  • J. Alexander (2001) LABORATORY EVALUATIONS IN MOLECULAR MEDICINE: Nutrients, Toxicants and Cell Regulators. Inst. for Advances in Mol. Med., ISBN 0967394910
  • Melvyn R. Werbach, Jeffrey Moss (1999) Textbook of Nutritional Medicine, Third Line Press, ISBN 0-9618550-9-6
  • Joseph E. Pizzorno, Jr., Michael T. Murray (November 2005) Textbook of Natural Medicine, 3rd edition, Churchill Livingstone, ISBN 0-443-07300-7 · 2368pp

Critics

  • Barrie R. Cassileth (1998) Alternative medicine handbook: the complete reference guide to alternative and complementary therapies. New York: W.W.Norton & Co., ISBN 0-393-04566-8

See also

External links

Journals

Support

Criticism

Footnotes and Reference links
  1. The War Against Vitamin Therapy doctoryourself.com , Andrew Saul, PhD - Accessed, August 2006
  2. The American Heritage Stedman's Medical Dictionary, 2nd Edition, 2004.
  3. ^ Definition of Orthomolecular medicine at www.orthomed.org Accessed June 2006
  4. ^ What is Orthomolecular Medicine?, Linus Pauling Inst. Oregon State University , Accessed August 2006
  5. ^ Cassileth BR. Alternative medicine handbook: the complete reference guide to alternative and complementary therapies. New York: W.W.Norton & Co., 1998:67.
  6. ^ Orthomolecular Therapy, Barrett S, Quackwatch, accessed 6 Nov 2006 criticism of two early, orthomolecular psychiatry treatments
  7. ^ Orthomolecular Medicine Revisited, Wunderlich RC, Orthomolecular Medicine Online, accessed 6 Nov 2006 Cite error: The named reference "wund" was defined multiple times with different content (see the help page).
  8. OMACOR(omega-3-acid ethyl esters), Reliant Pharmaceuticals, Inc.
  9. Greene R, Cortez MF. Abbott to Buy Kos Pharmaceuticals for $3.7 Billion (Update2). Bloomberg.com, 6 Nov 2006.
  10. Orthomolecular Medicine News Service (OMNS) Listing or research and news items favourable to the Orthomolecular point of view
  11. How safe are vitamins? Orthomolecular Medicine News Service, November 9, 2005 - Accessed August 2006
  12. Observations On the Dose and Administration of Ascorbic Acid When Employed Beyond the Range of a Vitamin in Human Pathology
  13. Alpha-Lipoic Acid (Thioctic Acid): My Experience
  14. Reduction of Cholesterol and Lp(A) in Regression of Coronary Artery Disease: A Case Study
  15. Coenzyme Q10: A Novel Cardiac Antioxidant (1997)
  16. New/Old Findings on Unique Vitamin E
  17. AscorbateWeb: Timeline from 1935 to 1939
  18. Orthomolecular psychiatry. Varying the concentrations of substances normally present in the human body may control mental disease,Science 1968 Apr 19;160(825):265-71. (PMID 5641253)
  19. Definition of Orthomolecular medicine at www.orthomed.org Accessed June 2006 and What is Orthomolecular Medicine?, Linus Pauling Inst.
  20. Plaza SW, Lamson DW. . Alt Medicine Review, Vol 10, No 1.
  21. Hoffer A, et al. Treatment Protocol for Alcoholism. Orthomolecular Medicine News Service, 1 Jul 2005
  22. Princeton Brain Bio Center. Brochure, distributed to patients. Skillman, N.J., 1983, The Center.
  23. Skinner P, "Orthomolecular Medicine", Gale Encyclopedia of Alternative Medicine: Holistic medicine, Thomson Gale, 2004.
  24. ^ http://orthomed.org/kunin.html Principles That Identify Orthormolecular Medicine: A Unique Medical Specialty by Richard A. Kunin Cite error: The named reference "kunin" was defined multiple times with different content (see the help page).
  25. NCCAM.NIH table 1 on page 8
  26. Strader DB, Bacon BR, Lindsay KL, La Brecque DR, Morgan T, Wright EC, Allen J, Khokar MF, Hoofnagle JH, Seeff LB. Use of complementary and alternative medicine in patients with liver disease. Am J Gastroenterol. 2002 Sep;97(9):2391-7.
  27. http://orthomed.org Orthomolecular Medicine Online
  28. Smith GCS, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ 2003;327:1459-1461 (20 December)
  29. DJ Hess, Complementary or Alternative? Stronger vs Weaker Integration Policies Am J Public Health. 2002 October; 92(10): 1579–1581.
  30. Lexchin J, Light DW. Commercial influence and the content of medical journalsBMJ 2006;332:1444-1447 (17 June)
  31. The Acid Test For Schizophrenia, essay, 2005, accessed September 10, 2006
  32. Hoffer's Home Page -The Schizophrenias, accessed September 10, 2006
  33. P. Scott, E. Richards, B. Martin, Captives of Controversy: The Myth of the Neutral Social Researcher in Contemporary Scientific Controversies, Science, Technology, & Human Values, Vol. 15, No. 4, Fall 1990, pp. 474-494, accessed September 10, 2006
  34. Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM, Bor DH. Timing of New Black Box Warnings and Withdrawals for Prescription Medications. JAMA. 2002;287:2215-2220.
  35. http://www.doctoryourself.com/hoffer_cardio.html
  36. ^ Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith CL, Taylor JR. JAMA 1996 ;276:1957-63 PMID 8971064 200ug/d of selenium for 4.5 years resulted in a 17% reduction of totality mortality by over 11 years (in total), due to a 50% reduction of (all) cancer mortality, 37% reduction in (all) cancer occurrence
  37. ^ Reduction of cancer mortality and incidence by selenium supplementation. Combs GF Jr, Clark LC, Turnbull BW in Med Klin 1997 ;92 Suppl 3:42-5. PMID 9342915
  38. ^ Reduction of cancer risk with an oral supplement of selenium. Combs GF Jr, Clark LC, Turnbull BW in Biomed Environ Sci 1997;10:227-34 PMID 9315315
  39. J Urol. 1994 Jan;151(1):21-6. Megadose vitamins in bladder cancer: a double-blind clinical trial.Lamm DL, Riggs DR, Shriver JS, vanGilder PF, Rach JF, DeHaven JI. PMID 8254816 "The 5-year estimates of tumor recurrence are 91% in the RDA arm and 41% in the megadose arm"
  40. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ, Fuchs C, Rosner BA, Speizer FE, Willett WC; Ann Intern Med" 1998 Oct 1;129(7):517-24 PMID 9758570 Long-term use (>15 years) of folate-containing multivitamin supplements produced an almost 5-fold reduction in the incidence of colon cancer.
  41. Ridker PM; Ballantyne CM. MD)[http://www.lipidsonline.org/slides/slide01.cfm?q=omacor&dpg=1 Effects of n-3 Fatty Acid Therapy on Lipids and sCAMs], slide, Lipids Online, Baylor College of Medicine, 3 Oct 2001, accessed 10 Nov 2006
  42. http://www.ajcn.org/cgi/content/full/77/2/279?ijkey=9ab8b23f0bdf45f83af656d8623815f69608ad01&keytype2=tf_ipsecsha
  43. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E in 11,324 patients with myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354:447–55.
  44. Orthomolecular Research
  45. ^ Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Losonczy KG, Harris TB, Havlik RJ in Am J Clin Nutr 1996 Aug;64(2):190-6 PMID: 8694019 over 9 years of vitamin E found a 34% reduction in total mortality along with a 47% reduction coronary disease mortality; over 9 years from vitamin C & E use found a 42% reduction in total mortality with a 53% reduction in coronary disease mortality
  46. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. Canner PL, Berge KG, Wenger NK, Stamler J, Friedman L, Prineas RJ, Friedewald W in J Am Coll Cardiol 1986 Dec;8(6):1245-55 PMID: 3782631 "With a mean follow-up of 15 years, nearly 9 years after termination of the trial, mortality from all causes in each of the drug groups, except for niacin, was similar to that in the placebo group. Mortality in the niacin group was 11% lower than in the placebo group (52.0 versus 58.2%; p = 0.0004)." Dose used = 2g 3g/day for 6 years. The drop in mortality was only evident after 6-8 years.
  47. Associations of Mortality With Ocular Disorders and an Intervention of High-Dose Antioxidants and Zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. AREDS Research Group (Authors: Traci E. Clemons, PhD; Natalie Kurinij, PhD; Robert D. Sperduto, MD.) in Arch Ophthalmol. 2004 May;122(5):716-26. PMID: 15136320 "Participants randomly assigned to receive zinc had lower mortality than those not taking zinc (RR, 0.73; 95% CI, 0.61-0.89)."
  48. Vitamin C intake and mortality among a sample of the United States population. Enstrom JE, Kanim LE, Klein MA in Epidemiology 1992 May;3(3):194-202 (PMID 1591317) 35% reduction in mortality over 10 years from vitamin C use
  49. Bruce N Ames, Ilan Elson-Schwab and Eli A Silver (2002). "High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphisms". American Society for Clinical Nutrition. 75: 616–658. Retrieved 2006-08-12.
  50. Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L- carnitine and/or R-alpha -lipoic acid. Liu J, Killilea DW, Ames BN in Proc Natl Acad Sci U S A 2002 Feb 19;99(4):1876-81 (PMID 11854488)
  51. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha -lipoic acid. Liu J, Head E, Gharib AM, Yuan W, Ingersoll RT, Hagen TM, Cotman CW, Ames BN in Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2356-61. (PMID 11854529)
  52. Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Hagen TM, Liu J, Lykkesfeldt J, Wehr CM, Ingersoll RT, Vinarsky V, Bartholomew JC, Ames BN in Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):1870-5. (PMID 11854487)
  53. ^ http://www.juvenon.com/pdfs/june05_ames-prescrip.pdf
  54. ^ http://reason.com/amesint.shtml
  55. Vitamins for chronic disease prevention in adults: clinical applications. Fletcher RH, Fairfield KM in JAMA 2002 Jun 19;287(23):3127-9 (PMID 12069676) “Most people do not consume an optimal amount of all vitamins by diet alone. Pending strong evidence of effectiveness from randomized trials, it appears prudent for all adults to take vitamin supplements. We recommend that all adults take one multivitamin daily. It is reasonable to consider a dose of 2 ordinary multivitamins daily in the elderly”
  56. Vitamins for chronic disease prevention in adults: scientific review. Fairfield KM, Fletcher RH in JAMA 2002 Jun 19;287(23):3116-26 (PMID: 12069675) “Although the clinical syndromes of vitamin deficiencies are unusual in Western societies, suboptimal vitamin status is not .”
  57. Vivekananthan D, Penn M, Sapp S, Hsu A, Topol E (2003). "Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials". Lancet. 361 (9374): 2017–23. PMID 12814711.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  58. Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold J, Ross C, Arnold A, Sleight P, Probstfield J, Dagenais G (2005). "Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial". JAMA. 293 (11): 1338–47. PMID 15769967.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  60. Spencer JW, Jacobs JJ. Complementary/alternative medicine: an evidence based approach. Toronto: Mosley, 1999:134,137; The selenium shocker. University of California at Berkeley Wellness Letter 1997;13:8-9; http://www.news.cornell.edu/releases/Jan97/selenium.ssl.html
  61. ^ "Vitamin Therapy, Megadose / Orthomolecular Therapy" British Columbia Provincial Health Services Authority 2000
  62. http://www.tinussmits.nl/english/dynamic.htm?main=http://www.tinussmits.com/english/autism.htm
  63. http://www.canstats.org/readdetail.asp?id=542
  64. Marcia Angell, (August 24, 2004) The Truth About the Drug Companies: How They Deceive Us and What to Do About It, Random House, 1st ed, ISBN 0-375-50846-5
  65. Text of the Dietary Supplement Health and Education Act of 1994, legislating that vitamin supplements are regulated as foods rather than as medications. Accessed 21 Sept 2006.
  66. Falloon W. What Do “Regulated” Supplements Cost. LE Magazine (online archives), July 2005, p 1
  67. The Ascorbate Effect in Infectious and Autoimmune Diseases Fourth World Conference on Nutritional Medicine, San Francisco, June 2004.
  68. Hasslberger S. Vitamin C could be effective against SARS. New Media Explorer. 6 June 2003 includes republication of article: Mawhinney J. "Vitamin C touted to fight virus." Toronto Star, 30 May 2003.
  69. Saul A, How to Spot Anti- Vitamin Research: Ten Ways to Spot Anti-Vitamin Biases in a Scientific Study, DoctorYourself.com, accessed 1 Nov 2006
  70. Hoffer A, FACTS AND FACTOIDS: An Information Sheet for Patients, DoctorYourself.com, accessed 1 Nov 2006
  71. Pauling L, (1976) Vitamin C, the Common Cold, and the Flu, W H Freeman & Co , ISBN 0-7167-0361-0
  72. ^ Douglas RM, Hemila H (2005). "Vitamin C for preventing and treating the common cold". PLoS Med. 2 (6): e168, quiz e217. PMID 15971944.
  73. American Cancer Society 2006 "Orthomolecular Medicine has not been definitively or authoritatively proven to help many of the conditions for which it recommends treatments. However, vitamins, minerals, and other supplements have been and continue to be studied to see if they can help or prevent many types of illness."
  74. Nutrition Committee, Canadian Paediatric Society. Megavitamin and megamineral therapy in childhood. Canadian Medical Association Journal 143:1009-13, 1990, reaffirmed April 2000.
  75. The Dark Side of Linus Pauling's Legacy by Stephen Barrett
  76. Padayatty SL et al., Vitamin C Pharmacokinetics: Implications for Oral and Intravenous Use Ann Intern Med 2004;140:533-7.
  77. Committee on Nutrition, American Academy of Pediatrics. Megavitamin therapy for childhood psychoses and learning disabilities. Pediatrics 58:910­912, 1976. PMID 995522
  78. emedicine - Toxicity statistics, 2003
  79. Rapola JM, et al. Randomized trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997;349;1715-20.
  80. PMID 3153129
  81. PMID 3737019
  82. Roberts HJ. Vitamin E . Lancet 1995 Mar 18;345:737
  83. Kaegi E, on behalf of the Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative. Unconventional therapies to cancer: 5. Vitamins A, C, and E. Canadian Medical Association 1998; 158:1483-88.
  84. http://www.quackwatch.org/01QuackeryRelatedTopics/DSH/colds.html
  85. http://www.doctoryourself.com/testimony.htm TESTIMONY by Andrew W. Saul before the Government of Canada, House of Commons Standing Committee on Health, regarding natural health product safety (Ottawa, May 12, 2005).
  86. http://www.emedicine.com/EMERG/topic638.htm
  87. Horwitt MK, et al, Serum concentrations of a-tocopherol after ingestion of various vitamin E preparations, Am J Clin Nutr 1984;40: 240-245. The rat-fetal-resorption test currently is used to assess the biological activity of vitamin E compounds. Previous studies in humans, however, suggest that rat assays underestimate the potency of free tocopherol relative to the acetate ester form and of RRR-a-tocopheryl acetate relative to all-rac-a-tocopheryl acetate. Therefore, we studied...20 adult human subjects. Measurements...of 800 IU of the various preparations...at 24 h...mean increase in concentration of a-tocopherols (mg/g lipid) in 24 h was 71.2% after RRR-a-tocopherol, 63.3% after RRR-a-tocopher acetate plus apple pectin, 60.9% after RRR-a-tocopher acetate, 31.6% after all-rac-a-tocopher acetate, and 41.2% after RRR-a-tocopher succinate. Animal assay data do not correlate with data from studies of absorption and retention in serum of a-tocopherols ingested by humans.
  88. Jiang Q et al.Gamma tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr 2001; 74: 714-22.
  89. JM Gaziano, Vitamin E and Cardiovascular Disease: Observational Studies, Ann. N.Y. Acad. Sci. 1031: 280–291 (2004) "
  90. Vivekananthan D, Penn M, Sapp S, Hsu A, Topol E (2003). "Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials". Lancet. 361: 2017–23. PMID 12814711. {{cite journal}}: Italic or bold markup not allowed in: |journal= (help)CS1 maint: multiple names: authors list (link)
  91. M Walker, New/Old Findings on Unique Vitamin E, Townsend Letter for Doctors and Patients, No. 111, 1992, p. 826
  92. L MacWilliam,What Makes Gamma Tocopherol Superior to Alpha Tocopherol, LE Magazine, Report, April 2006
  93. ^ M. Houston, “Meta-Analysis, Metaphysics and Mythology” JANA Vol. 8 No. 1, 2005 original
  94. Miller E, Pastor-Barriuso R, Dalal D, Riemersma R, Appel L, Guallar E (2005). "Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality". Ann Intern Med. 142: 37–46. PMID 15537682. {{cite journal}}: Italic or bold markup not allowed in: |journal= (help)CS1 maint: multiple names: authors list (link)
  95. Carter, T. Responses and Comments: High-Dosage Vitamin E Supplementation and All-Cause Mortality, Ann Intern Med. 2005 Jul 19;143(2):155; responses 150-160
  96. Dam HCP. Influence of antioxidants and redox substances on signs of vitamn E defciency. Pharmacol Rev 1957 9: 1-16.
  97. Hoskins FH. (1980) Antinutrients, Kirk-Othmer Encyclopedia of Chemical Technology, 3rd Edition, John Wiley & Sons, New York, pp 213-214
  98. PMID 16027469
  99. Jialal I, Devaraj S. Antioxidants and atherosclerosis: don't throw out the baby with the bath water. Circulation. 2003 Feb 25;107(7):926-8. (Comment on: Circulation. 2003 Feb 25;107(7):947-53.) PMID 12600900
  100. Schectman G, Byrd JC, Gruchow HW. The influence of smoking on vitamin C status in adults. Am J Public Health. 1989 February; 79(2): 158–162.
  101. Stone I. Smoker’s Scurvy: Orthomolecular Preventive Medicine in Cigarette Smoking. Orthomolecular Psychiatry, 1976, Vol 5, No 1, pp. 35-42
  102. Hercberg S, Galan P, et al, The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med. 2005 Feb 14;165(3):286.
  103. JM Geleijnse, C Vermeer, DE Grobbee, LJ Schurgers, MHJ Knapen, IM van der Meer, A Hofman, JCM Witteman, Dietary Intake of Menaquinone Is Associated with a Reduced Risk of Coronary Heart Disease: The Rotterdam Study J. Nutr. 134:3100-3105, November 2004
  104. Pizzorno JE, Murray MT (November 2005) Textbook of Natural Medicine, 3rd edition, Churchill Livingstone, ISBN 0-443-07300-7, Chapters 12, 14, 24, 59, 181
  105. Educational Documents, CDSA 2.0 Universal Kit Guide, Digestive Analysis Solution Center, Genova Diagnostics, accessed 2 Nov 2006
  106. http://www.healthwatcher.net/Quackerywatch/Cancer/Dueck/index.html
  107. Klenner, FR. Observations On the Dose and Administration of Ascorbic Acid When Employed Beyond the Range Of A Vitamin. Human Pathology Journal of Applied Nutrition Vol. 23, No's 3 & 4, Winter 1971.
  108. Klenner FR. Virus Pneumonia and Its Treatment With Vitamin C. Southern Med Surg, v110, no 2, p36, 1948.
  109. Klenner FR. The Treatment of Poliomyelitis and Other Virus Diseases with Vitamin C, Southern Med Surg, v111, no 7, p209, 1949.
  110. Klenner FR. The Use of Vitamin C as an Antibiotic. J Appl Nutr, vol 6, p274, 1953
  111. Multivitamin found to slow pace of HIV, Study examined Tanzanian women, The Boston Globe, July 1, 2004
  112. HD Foster Treating AIDS with Nutrition.
  113. http://www.doctoryourself.com/aids_cathcart.html RF Cathcart, Vitamin C in the Treatment of Acquired Immune Deficiency Syndrome (AIDS), Medical Hypotheses 14:423-433, 1984
  114. Eylar E, et al. Sustained levels of ascorbic acid are toxic and immunosuppressive for human T cells. Puerto Rico Health Sciences Journal 1996;15:21-6
  115. DR Brown, Theoretical estimation of blood mercury levels from Thimerosal injections using a one compartment biokinetic model. IOM Meeting, Boston, July 16, 2001
  116. Gideon K, Julia Klein J, Neonatal hair test for cocaine:Toronto experience. July, 1997
  117. http://www.quackwatch.org/01QuackeryRelatedTopics/hair.html
  118. Director's newsletter, Linus Pauling Institute, Spring 2006
  119. OMACOR deal signed with new Euro partners, HYDRO, 11 Dec 2001
  120. fibrinolytic activity of nattokinase, Miyazaki Medical College, Japan
  121. Coenzyme Q10, prescribed for CHF in Japan since 1974, AAFP
  122. Kaitin, KI, Brown, J. 1995. A Drug Lag Update. Drug Information Journal 29:361–73
  123. Abram Hoffer in Book Reviews in The Journal of Orthomolecular Medicine Vol. 11, 4th Quarter 1996
  124. Abram Hoffer in Book Reviews in The Journal of Orthomolecular Medicine Vol. 11, 4th Quarter 1996
  125. History of the Journal of Orthomolecular Medicine by Abram Hoffer.
Categories: